The FDA Just Made Peptide Therapy Clearer and Safer. Here's What That Means for You

Key Takeaways

Updated FDA guidance clarifies which peptides can be compounded and how they must be handled.
The changes reward clinics that already operate under strict medical and pharmacy standards.

What Changed

New guidance draws a clearer line between compounded peptides prepared under medical supervision and unregulated products sold online. For patients, that means more transparency about what they are actually receiving.

Why It Matters for Patients

Clearer rules make it easier to identify a clinic that follows the science. At Mantality, protocols already run through licensed physicians and vetted pharmacies, so the guidance simply confirms the standard we hold.

Clinical Consultation